SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Biotech: Lack of Market For Biofuels Spurs Flexibility
Biofuels don’t hold the same cachet or glamour they once had, but companies like San Diego’s Genomatica Inc. are showing that the market opportunity is still there for biorenewable products. In particular, specialty chemicals and nutritional supplements are proving to be economically viable industries in the sustainability space.
A jury has ordered medical device maker NuVasive Inc. to pay $30 million to Ventura-based NeuroVision Medical Products Inc. for infringing on the trademark “NeuroVision.”
Biotech and tech stocks have been in a slump for the past three weeks, evidenced in part by the 3.1 percent drop in the Nasdaq Composite — the worst one day percentage decline, according to MarketWatch, since November 2011.
The Food and Drug Administration has halted the study of Halozyme Therapeutics Inc.’s pancreatic cancer treatment trial, just few days after the company voluntary stopped patient enrollment in the drug’s clinical trials.
The California Department of Public Health could fine Palomar Health up to $250,000 in connection with the theft of flash drives containing patient data.
Lumena Pharmaceuticals Inc. has filed for a $75 million initial public offering, just a few weeks after it closed a $45 million Series B financing round.
Kaiser Permanente has named Jane Finley to the position of senior vice president and executive director for the San Diego area.
Zogenix Inc. filed a lawsuit in the U.S. District Court in Massachusetts, the company said, seeking a temporary restraining order barring actions announced by Gov. Deval Patrick — namely, a prohibition against prescribing and dispensing Zohydro ER, Zogenix’s painkiller that was approved last year by the Food and Drug Administration.
Vital Therapies Inc. lowered the proposed size of its planned initial public offering, according to Renaissance Capital. Vital Therapies now plans to sell 4.5 million shares at $13 to $15 per share, expecting to raise about $63 million.
The newly formed San Diego cancer drugmaker Seragon Pharmaceuticals Inc. has appointed Debasish Roychowdhury as its new acting chief medical officer.
A startup company at work on a unique medical device — a photosynthetic scaffold technology that helps restore damaged or diseased tissue — won a university business competition and $6,000.
In this brave new world of genome sequencing, where some San Diego companies are venturing, the promise of society-changing science comes with undeniable ethical issues.
PHARMA: Stock Takes Hit, But Co. Defends Painkiller
Zogenix Inc. is in damage control mode as it faces a maelstrom of criticism for its newly launched narcotic painkiller.
Cytori Therapeutics named Marc Hedrick to the position of CEO, after announcing the retirement of Christopher Calhoun from that position.
Two companies founded by genomics pioneer J. Craig Venter are expanding their real estate footprint in La Jolla, leasing additional space from BioMed Realty Trust Inc.